Back

Diminished preconditioning potential in the hearts from metabolic syndrome subjects can be partially restored by angiotensin-converting-enzyme inhibitor therapy

28 August 2018 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Coronary artery disease - Diagnosis, pharmacotherapy and revascularisation Treatment, Other ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Aziza Yakubova

Terumo Europe, Leuven (Belgium)

16 More presentations in this session

Presentation thumbnail
Associate Professor A. Bendary (Benha, EG)
Abstract Slides
Presentation thumbnail
Doctor A. Hohneck (Mannheim, DE)
Abstract Slides
Presentation thumbnail
Doctor J. Won (Gwangju, KR)
Abstract
Presentation thumbnail
Professor M. Glezer (Moscow, RU)
Abstract
Presentation thumbnail
Doctor G. Yoshioka (Saga, JP)
Abstract

Access the full session

Session thumbnail
Poster Session 7 - Coronary artery disease - Diagnosis, pharmacotherapy and revascularisation

The Event

Event poster

ESC Congress 2018

28 August 2018 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Cardioprotective effect of angiotensin converting enzyme 2 activation in hESC-derived cardiomyocytes under diabetic condition
21 May 2023
thumbnail
Congress Presentation
Prevalence and impact of metabolic syndrome in patients with multivessel coronary artery disease and acute coronary syndrome
27 August 2021
thumbnail
Congress Presentation
Cigarette smoking abolishes the mediterranean diet benefit on exercise capacity, coronary physiology and target organ damage in hypertensive males with erectile dysfunction
26 August 2023
thumbnail
Congress Session
Redefining mineralocorticoid receptor antagonism in cardio-kidney-metabolic syndrome: from evidence to innovation
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources